CNBX Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $6.6M | $3.6M | $1.4M |
| FY2018 | $539.4K | $3.2M | $1.4M |
| FY2019 | $438.9K | $15.2M | $266.0K |
| FY2020 | $454.8K | $2.2M | $777.6K |
| FY2021 | $1.3M | $3.1M | $1.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $6.6M | $3.6M | $1.4M |
| FY2018 | $539.4K | $3.2M | $1.4M |
| FY2019 | $438.9K | $15.2M | $266.0K |
| FY2020 | $454.8K | $2.2M | $777.6K |
| FY2021 | $1.3M | $3.1M | $1.4M |